Latest hum. ProductsDetails
Product Name in the RMS: Numeta G13E
MR Number: SE/H/0918/004
Date of outcome: 15.03.2016
| Type of application | |
|---|---|
|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Line Extension Additional Strength/Form Fixed Combination Chemical Substance Prescription Only |
| Active Substances |
alanine 4,66 g arginine 4,89 g aspartic acid 3,5 g calcium chloride dihydrate 3,45 g cysteine 1,1 g glucose monohydrate 550 g glutamic acid 5,83 g glycine 2,33 g histidine 2,21 g isoleucine 3,9 g leucine 5,83 g lysine 6,41 g MAGNESIUM ACETATE tetrahydrate 0,63 g methionine 1,4 g ornithine 1,45 g phenylalanine 2,45 g potassium acetate 3,83 g proline 1,75 g serine 2,33 g sodium glycerophosphate hydrate 6,15 g taurine 0,35 g threonine 2,16 g tryptophan 1,17 g tyrosine 0,45 g valine 4,43 g |
| Form | Emulsion for infusion |
| MA Holder in the RMS |
Baxter Medical AB Sweden |
| RMS | Sweden |
| Date of last change | 19.02.2021 |
| ATC-Code |
B05BA10 Combinations |
| CMS Country | Domestic Product Name |
|---|---|
| Austria | Numeta G 13 % E Emulsion zur Infusion |
| Belgium | Numetzah G13%E émulsion pour perfusion |
| Czech Republic | Numeta G13%E |
| Denmark | Numeta G13E |
| Finland | |
| France | |
| Germany | Numeta G 13 % E |
| Greece | NUMETA® PRETERM |
| Ireland | |
| Italy | |
| Luxembourg | |
| Malta | |
| Netherlands | |
| Norway | Numeta G13E |
| Poland | NUMETA G13% E Preterm |
| Portugal | |
| Spain | |
| United Kingdom |
| Documents | |
|---|---|
| PAR: | https://lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20150326000025 (01.11.2016) |
| PARSummary: | https://lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20150326000025 (01.11.2016) |
| FinalSPC: | https://lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20150326000025&type=product (17.05.2016) |
| FinalPL: | https://lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20150326000025&type=product (17.05.2016) |
